Jpmorgan Chase & CO Zimmer Biomet Holdings, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 3,562,920 shares of ZBH stock, worth $386 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,562,920
Previous 3,478,359
2.43%
Holding current value
$386 Million
Previous $459 Million
15.77%
% of portfolio
0.03%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding ZBH
# of Institutions
1,089Shares Held
185MCall Options Held
313KPut Options Held
475K-
Vanguard Group Inc Valley Forge, PA23.4MShares$2.54 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY16.8MShares$1.83 Billion0.04% of portfolio
-
Dodge & Cox San Francisco, CA16.7MShares$1.82 Billion1.15% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.5MShares$1.36 Billion0.16% of portfolio
-
State Street Corp Boston, MA9.22MShares$999 Million0.04% of portfolio
About ZIMMER BIOMET HOLDINGS, INC.
- Ticker ZBH
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 209,820,000
- Market Cap $22.7B
- Description
- Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...